Anxiety Disorders Terminated Phase 2 Trials for Riluzole (DB00740)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00805493Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar DisorderTreatment